Expertise in
6
conditions

Dr. Heiko C. Konig

Oncology
Office
250 N Shadeland Ave Ste 130, 
Indianapolis, IN 
Accepting New Patients
Expertise in
6
conditions
Office
250 N Shadeland Ave Ste 130, 
Indianapolis, IN 

Overview

Heiko Konig is an Oncologist practicing medicine in Indianapolis, Indiana.

Dr. Konig is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Multiple Myeloma, Smoldering Multiple Myeloma, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 39 peer reviewed articles and participating in 2 clinical trials. Dr. Konig is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in IN

Hospital Affiliations

Eskenazi Health

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

CareSource
  • HMO

Locations

Office
250 N Shadeland Ave Ste 130, Indianapolis, IN 46219
Other Locations
Eskenazi Health
720 Eskenazi Ave, Indianapolis, IN 46202

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Enrollment Status: Active_not_recruiting
Publish Date: November 26, 2025
Intervention Type: Drug
Study Drugs: Ponatinib, Imatinib, Vincristine, Dexamethasone, Cytarabine, Methotrexate, Prednisone
Study Phase: Phase 3
Phase Ib Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113
Phase Ib Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113
Enrollment Status: Completed
Publish Date: May 04, 2025
Intervention Type: Drug
Study Drugs: Gemtuzumab Ozogamicin, Venetoclax
Study Phase: Phase 1
View 1 Less Clinical Trial

39 Total Publications

FLT3-SYK inhibitor and Ixazomib combination impact HOXA and oxidative stress control by β-catenin, SQSTM1 and NRF2 in AML.
FLT3-SYK inhibitor and Ixazomib combination impact HOXA and oxidative stress control by β-catenin, SQSTM1 and NRF2 in AML.
Journal: NPJ precision oncology
Published: November 12, 2024
Similar Doctors
Expertise in
20
conditions
Expertise in
20
conditions
Referral may be required

Indiana University Health University Hospital

550 University Blvd, 
Indianapolis, IN 
 (6.9 miles away)
317-944-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lawrence Einhorn is an Oncologist practicing medicine in Indianapolis, Indiana. Dr. Einhorn is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Testicular Cancer, Teratoma of the Mediastinum, Testicular Yolk Sac Tumor, Mediastinal Tumor, and Orchiectomy. Dr. Einhorn is currently accepting new patients.

Expertise in
20
conditions
Expertise in
20
conditions
Referral may be required

Univ. Radiation Oncology Associates Inc.

535 Barnhill Dr, 
Indianapolis, IN 
 (7.0 miles away)
317-944-0920
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Nasser Hanna is an Oncologist practicing medicine in Indianapolis, Indiana. Dr. Hanna is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Testicular Cancer, Teratoma of the Mediastinum, and Orchiectomy. Dr. Hanna is currently accepting new patients.

Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required

Indiana University Health University Hospital

550 University Blvd, 
Indianapolis, IN 
 (6.9 miles away)
317-944-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kathy Miller is an Oncologist practicing medicine in Indianapolis, Indiana. Dr. Miller is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Breast Cancer in Men, and Salpingo-Oophorectomy. Dr. Miller is currently accepting new patients.

Frequently Asked Questions about Dr. Heiko C. Konig

How do I make an appointment with Dr. Heiko C. Konig?

You can book an appointment with Dr. Heiko C. Konig by calling their office at 317-948-6260. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Heiko C. Konig a top-rated expert for Chronic B-Cell Leukemia (CBCL)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Heiko C. Konig is classified as an Distinguished expert for Chronic B-Cell Leukemia (CBCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Heiko C. Konig specialize in?

While Dr. Heiko C. Konig is a Oncology, they have specific expertise in Chronic B-Cell Leukemia (CBCL), Multiple Myeloma, and Smoldering Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Heiko C. Konig participate in research or clinical trials?

Yes. Dr. Heiko C. Konig has published 39 articles and abstracts on conditions like Chronic B-Cell Leukemia (CBCL). You can view a list of Dr. Heiko C. Konig's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Heiko C. Konig accept my insurance?

Dr. Heiko C. Konig accepts most major insurance plans, including CareSource. We recommend calling the office directly at 317-948-6260 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Konig's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile